Andrews, M C
Cancer Evolution during Immunotherapy. [electronic resource]
- Cell 11 2017
- 740-742 p. digital
Publication Type: Journal Article; Comment
1097-4172
10.1016/j.cell.2017.10.027 doi
Humans
Immunity
Immunotherapy
Melanoma
Nivolumab
Programmed Cell Death 1 Receptor
Tumor Microenvironment